Biofrontera BFRI
NASDAQ BFRI
$0.80 0.00 (-0.50%)
At close: Oct 21, 2026 · 4:00 PM EDT

Biofrontera (BFRI) Short-Term Debt repayments (2023 - 2024)

Updated

Biofrontera (BFRI) recorded Short-Term Debt repayments of $357,000 in Q4 2024, down 96.2% from $9.5 million a year earlier but up 19.8% from the prior quarter.

Analysis

Biofrontera (BFRI) Short-Term Debt repayments (2023 - 2024) Analysis & Trends

For FY2024, Biofrontera reported Short-Term Debt repayments of $4.32 million, down 79.8% from FY2023.

  • Across earlier years, Short-Term Debt repayments came in at $21.34 million in FY2023.
  • Quarterly Short-Term Debt repayments has ranged from $298,000 in Q3 2024 to $9.5 million in Q4 2023 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $298,000 (Q3 2024), $2.15 million (Q2 2024) and $1.51 million (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 6.45 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Biofrontera 10.34 Mn -11.45 Mn 9.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 298,000.00
Jun 30, 2024 2.15 Mn
Mar 31, 2024 1.86 Mn
Dec 31, 2023 9.50 Mn
Sep 30, 2023 7.26 Mn
API Access

Biofrontera Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=BFRI&period=max&api_key=YOUR_API_KEY